Bringing Psilocybin to Market: Compass’ Steve Levine on Infrastructure, Access and Competition Post published:November 26, 2025 Post category:Interviews/Pα+
The Psychedelic News Feed: November 17 – 23, 2025 Post published:November 24, 2025 Post category:Psychedelic News Feed Archive
ARPA-H Launches $100M Effort to “Demystify” Mental Health and Catalyse Rapid-Acting Behavioural Health Therapeutics, Including Psychedelics Post published:November 22, 2025 Post category:Analysis/News/Pα+
Pα+ Psychedelic Bulletin #214: LSD Microdosing Program Collapses; AtaiBeckley’s Phase 2b Debrief; UK Government Responds to MPs’ Psilocybin-Related Questions Post published:November 19, 2025 Post category:Psychedelic Bulletin/Pα+
The Psychedelic News Feed: November 10 – 16, 2025 Post published:November 17, 2025 Post category:Psychedelic News Feed Archive
Beyond the Brain Reset: Óscar Soto on Mechanisms of Psychedelic Action Post published:November 13, 2025 Post category:Interviews
The Psychedelic News Feed: November 3 – 9, 2025 Post published:November 10, 2025 Post category:Psychedelic News Feed Archive
AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots Phase 3 Post published:November 10, 2025 Post category:Analysis/News/Pα+
Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate Post published:November 7, 2025 Post category:Psychedelic Bulletin/Pα+
Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months Post published:November 4, 2025 Post category:Analysis/News/Pα+